October is #BreastCancerAwarenessMonth and the #CCTG MAC27 trial is investigating if the combination of a new drug and a commonly used drug is better at preventing HER2-positive #breastcancer from returning #BreastCancerCanada, #BCAM, #PinkForBreastCancer buff.ly/X6OHJjN